ELDN · Eledon Pharmaceuticals, Inc.

$3.31 -0.10 (-2.79%) At close · Jul 29

Market Cap

$262.44M

77.19M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David-Alexandre Gros	CEO	$613,196	—	$268,660	$1,963,080	$349,522	$21,690	$3,216,148
Steven Perrin	President and Chief Scientific Officer	$484,919	—	$109,080	$795,048	$284,284	$22,953	$1,696,284
Paul Little	CFO	$479,226	—	$303,000	$572,565	$215,172	$22,980	$1,592,943

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David-Alexandre Gros	CEO	$582,269	—	—	$4,577,034	$464,277	$21,390	$5,644,970
Steven Perrin	President and Chief Scientific Officer	$455,258	—	—	$3,787,094	$306,879	$21,990	$4,571,222
Paul Little	CFO	$459,431	—	—	$2,365,846	$242,378	$22,680	$3,090,335

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David-Alexandre Gros	CEO	$559,478	—	—	$1,686,802	$286,383	$20,490	$2,553,153
Steven Perrin	President and Chief Scientific Officer	$437,439	—	—	$906,435	$175,619	$21,090	$1,540,583
Paul Little	CFO	$441,448	—	—	$699,132	$159,506	$21,090	$1,321,176

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David-Alexandre Gros	CEO	$532,503	—	—	$310,538	$256,702	$18,750	$1,118,493
Paul Little	CFO	$421,051	—	—	$445,679	$175,031	$15,631	$1,057,392
Steven Perrin	President and Chief Scientific Officer	$417,052	—	—	$445,679	$167,256	$19,590	$1,049,577

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Little	CFO	$323,269	—	—	$1,851,199	$131,200	$2,290	$2,307,958
Bryan Smith	CFO	$276,923	$100,000	—	$1,305,600	—	$213	$1,682,736
David-Alexandre Gros	CEO	$503,654	—	—	—	$242,400	$1,450	$747,504
Steven Perrin	President and Chief Scientific Officer	$402,923	—	—	—	$161,600	$2,290	$566,813

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David-Alexandre Gros	CEO	$150,000	—	—	$7,176,879	—	$92,428	$7,419,307
Steven Perrin	President and Chief Scientific Officer	$122,308	—	—	$2,990,747	—	—	$3,113,055
Gregory J. Flesher	CEO	$364,496	$121,669	—	$611,826	—	$1,317,595	$2,415,586
Jon Kuwahara	Senior VP of Finance	$318,951	$45,045	—	$851,160	—	$3,138	$1,218,294

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gregory J. Flesher	CEO	$480,436	—	$66,847	$293,683	—	$1,698	$842,664
Catherine C. Turkel	President	$368,403	—	$53,478	$171,666	—	$4,110	$597,657
Senior Vice	President of Finance and Administration	$295,722	—	—	$95,679	—	$1,449	$392,850

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gregory J. Flesher	CEO	$459,865	—	$99,255	$191,327	$191,194	$1,440	$943,081
Catherine C. Turkel	President	$357,673	—	$64,661	$81,272	$118,965	$2,930	$625,501
Senior Vice	President of Finance and Administration	$281,065	—	$36,372	$40,636	$70,117	$1,391	$429,581

Key facts CIK 1404281 CUSIP 28617K101 13F (30d) 35 filings 35 filers Visit website Investor relations